leadf
logo-loader
NASDAQ:NVAX

Novavax, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$8.11 billion
Price
127.43 USD
Change
-1.96%
52 weeks high
189.40
52 weeks low
4.50

In brief

Novavax is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology.